1.
Ophthalmic Medication Expenditures and Out-of-Pocket Spending: An Analysis of United States Prescriptions from 2007 through 2016.
Chen Evan M, Kombo Ninani, Teng Christopher C, Mruthyunjaya Prithvi, Nwanyanwu Kristen, Parikh Ravi
OphthalmologyApr 202028 citationsCohort Study
US ophthalmic medication spending significantly rose (2007-2016), but patient out-of-pocket costs decreased, driven by glaucoma/dry eye drugs. This highlights rising overall costs despite lower direct patient burden.